Global 3D Printed Drugs Market Research and Forecast 2018-2027


Contact Information
Anurag Tiwari
116, Shagun Arcade, Vijay Nagar Square
Madhya Pradesh - 452001
+1-646-755-7667, +91-780-304-0404
"Growing usage of 3d printing technology in healthcare drives the global 3d printed drug market"

According to OMR analysis the global 3D printed drugs market is expected to grow at a significant CAGR during forecast period 2018-2023. However, currently, the market is still more research-based market. The global 3D cell culture market is segmented on the basis of dosage forms and technology. There are various 3D printing technologies used in pharmaceutical industry for developing 3D printed drugs. The technologies include inkjet printing, direct-write, zip dose, thermal inkjet (TIJ) printing, fused deposition modelling (FDM), powder bed printing and stereolithography (SLA). The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, regulations, market determinants, key company analysis, strategic analysis, market insights, company profiling, market segmentation, and geographical analysis.

"3D printing is also starting to gain popularity in medicine manufacturing industry. While it's hard to forecast the across-the-board replacement of current drug manufacturing processes, 3D printing is predicted to find a place in certain niche medications and in personalized drugs."

The main advantage of 3D printed drug technology is to make oral medications easy for patient facing issues in swallowing drugs. The 3D printed drugs technology produces highly porous, water soluble drugs which can be easily collapse within 10 seconds. The US Food and Drug Administration (USFDA) approved the first 3D printed drug, Spritam in 2015. It is the only available 3D printed drug in the market. Spritam was manufactured by Aprecia Pharmaceuticals Inc. (headquartered in US). Spritam drug is a redevelopment of the anti-epileptic seizure drug levetiracetam. It has a layered as well as highly porous structure which made it rapidly sucks in liquid, collapsing to form a suspension. The structured made by 3D printing technology is unique and can't be achieved by using conventional drug manufacturing methods. Aprecia Pharmaceuticals Inc. uses inkjet 3D printing technology known as ZipDose for manufacturing 3D printed drug.

The report covers:
Comprehensive research methodology of global 3D Printed Drugs Market
This report also includes detailed and extensive market overview with key analyst insights
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
Analysis of regional regulations and other government policies impacting the global 3D Printed Drugs Market
Insights about market determinants which are stimulating the global 3D Printed Drugs Market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

About Orion Market Research

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Our research majorly covers various domains such as healthcare, energy, IT, chemicals, and automobiles. We provide 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
For more information, visit:

biotechnology, pharmaceuticals, Healthcare


If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.